Skip to main content
OpenTrials

Clinical trial condition

Prostate Cancer Recurrent

Explore clinical trials studying Prostate Cancer Recurrent. Study availability and eligibility vary by location and protocol.

35 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Prostate Cancer Recurrent trial results

Not Yet Recruiting

A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment

NCT06922929

Conditions
Prostate Cancer Recurrent
Locations
  • Beijing Chao-Yang Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
View all 32 locations
View Trial Details
Completed

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

NCT05848011

Conditions
Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Neoplasms, Androgen-Insensitive Prostatic Cance, +17 more
Locations
  • United Medical Group Miami, Florida, United States
  • Orlando Health Cancer Institute Orlando, Florida, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 61 locations
View Trial Details
Completed

Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer

NCT04742361

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Excel Diagnostics and Nuclear Oncology Center Houston, Texas, United States
  • Huntsman Cancer Institute Salt Lake City, Utah, United States
View Trial Details

Related conditions